甲亢治疗后体重增加与生活质量受损相关
本研究纳入108例接受治疗的甲亢患者,中位随访41个月,平均体重增加7.2 kg,中位百分比体重增加8.8%。横断面分析显示,百分比体重增加与ThyPRO量表中「外观抱怨」及「疲劳与整体生活质量」领域评分下降显著相关,但与「焦虑与抑郁」领域无关。
要点
- 甲亢治疗后体重增加与外观抱怨及疲劳/整体生活质量受损独立相关。
- 体重增加与焦虑抑郁领域无显著关联。
- 甲亢治疗后的体重管理值得临床关注。
核心结论
- 甲亢治疗后体重增加与生活质量的大幅不良影响相关,表现为外观、疲劳与整体生活质量领域评分降低。
研究设计与样本
- 横断面研究,纳入108例确诊后6个月至8年接受治疗的甲亢患者,使用ThyPRO工具评估生活质量,采用广义线性模型分析。
主要发现
- 诊断时中位体重65.5 kg、BMI 23.9 kg/m2,最终评估时中位体重72.7 kg(p < 0.001)、BMI 26.5 kg/m2(p < 0.001)。
- 平均(标准差)体重增加7.2(6.2)kg,平均病程41(22.5)个月,中位百分比体重增加8.8%(4.3%, 17%)。
- 与一般人群常模数据相比,所有可比领域的生活质量均显著降低。
- 百分比体重增加与「外观抱怨」相关(logistic回归OR=1.11, p=0.008;GLM b=0.47, p=0.022, q=0.033)。
- 百分比体重增加与「疲劳与整体生活质量」相关(b=0.62, p=0.011, q=0.017),与「焦虑与抑郁」无关(b=-0.005, p=0.661)。
临床怎么用
- 甲亢治疗后应关注体重变化,并将其纳入生活质量评估与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is evidence of quality of life (QoL) impairment and weight gain in treated hyperthyroidism. It is not known whether treatment-related weight gain is associated with QoL impairment in this patient group of this cohort. Our primary aim was to examine whether percentage weight gain (PWG) after treatment of hyperthyroidism was associated with QoL impairment. METHODS: We enrolled patients with treated hyperthyroidism 6 months to 8 years after diagnosis. We obtained anthropometric measurements from a prospectively completed database. With a cross-sectional study design, we assessed QoL using the thyroid-specific patient-reported outcome (ThyPRO) tool. We pre-specified three dependent variables in ThyPRO: "cosmetic complaints," a composite of "tiredness and overall QoL" and "depressivity and anxiety" domains. We included age, sex, thyrotropin categories, comorbidities, and disease duration as covariates. We applied a generalized linear model (GLM) for the analysis. RESULTS: We included 108 patients, including 68 (63%) females, with a mean (standard deviation [SD]) age 50 (14.5) years. The median weight at diagnosis was 65.5 (interquartile range [IQR]: 58.7, 75.5) kg and BMI was 23.9 (21.9, 27.1) kg/m2, and at final evaluation, weight was 72.7 (64.1, 83.8) kg (p < 0.001) and BMI was 26.5 (23.9, 30.8) kg/m2 (p < 0.001). The mean (SD) weight gain observed was 7.2 (6.2) kg over a mean (SD) disease duration of 41 (22.5) months. Median PWG was 8.8% (4.3%, 17%). There was a significantly reduced QoL in all comparable domains against general population normative data. PWG was associated with "cosmetic complaints" (odds ratio = 1.11, p = 0.008 via logistic regression; b = 0.47, p = 0.022, q (adjusted p) = 0.033 via GLM) and "tiredness and overall QoL" (b = 0.62, p = 0.011, q = 0.017), but not with the "anxiety and depressivity" domains (b = -0.005, p = 0.661). CONCLUSIONS: Our study suggests that weight gain after treatment of hyperthyroidism is associated with a large adverse effect on QoL, with reduced scores on appearance, combined "tiredness and overall QoL" domains of the ThyPRO questionnaire. Management of weight change upon treatment of hyperthyroidism merits further clinical attention and research.
引用
- Kyriacou A, Kyriacou A, Lamnisos D, et al. Weight Gain after Treatment of Hyperthyroidism is Associated with Impairment of Quality of Life. Thyroid. 2025. PMID: 41448910. doi:10.1177/10507256251404868
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。